PTCT

#2358
PTC Therapeutics, Inc. - Common Stock
73.8 5 USD
+3.94%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
73.85
73.85
Range Annuel
44.17
87.50
Changement quotidien
+3.94%
Changement Mensuel
+13.98%
Evolution sur 6 mois
-11.23%
Changement Annuel
+50.99%
Clôture Précédente
71.0 5
Open
73.8 5
Low
73.8 5
High
73.8 5
Volume
158
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

PTC Therapeutics, Inc. - Common Stock

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.

Nouvelles